Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 53, 1085-1090, March 1, 1993]
© 1993 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsuo, K.-i.
Right arrow Articles by Kuwano, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsuo, K.-i.
Right arrow Articles by Kuwano, M.

Enhanced Expression of the DNA Topoisomerase II Gene in Response to Heat Shock Stress in Human Epidermoid Cancer KB Cells1

Ken-ichi Matsuo2, Kimitoshi Kohno, Seiji Sato, Takeshi Uchiumi, Hideyuki Tanimura, Yuji Yamada and Michihiko Kuwano

Department of Biochemistry [K. M., K. K., S. S., T. U., H. T., M. K.], Oita Medical University, Hasama-machi, Oita 879-55; Laboratory of Anticancer Drug Research [Y. Y.], Original Compound R. & D. Operation Center, Taiho Pharmaceutical Co., Hanno-city, Saitama 357; and Department of Biochemistry [M. K.], Kyushu University School of Medicine, Maidashi, Fukuoka 812, Japan

Type II DNA topoisomerase breaks both DNA strands, and many anticancer agents including etoposide (VP-16) and teniposide (VM-26) have been developed by targeting topoisomerase II molecules. In this study we examined whether expression of the topoisomerase II gene is regulated in response to heat shock stress in human epidermoid cancer KB cells. Exposure of KB cells to 42°C for 3 to 24 h permitted cell growth at a slightly reduced rate but still at an exponential rate, in comparison with that at 37°C, whereas exposure to 45°C for 15 to 120 min caused the almost complete cessation of exponential growth. There appeared 5-fold or higher increases in mRNA levels of both topoisomerase II and a heat shock protein, hsp-70, after exposure to 42°C for 3 h, but only a slight, if any, increase in topoisomerase I mRNA. Nuclear run-on assays showed increased transcription of topoisomerase II and the hsp-70 gene after exposure to 42°C. By contrast, KB cells induced a rapid and transient increase of topoisomerase II mRNA after exposure to 45°C for 15 to 30 min, whereas the cellular level of hsp-70 mRNA was dramatically enhanced 60 min after exposure to 45°C. The immunoblot assay also demonstrated increased expression of topoisomerase II in KB cells exposed to 42°C. Decatenation activity of the nuclear extracts from KB cells was increased 1.5-fold by exposure to 42°C, but there appeared no increase in topoisomerase I activity. Prior exposure of KB cells to 42°C enhanced the cytotoxicity of VP-16, but not that of a topoisomerase I-targeting agent, a camptothecin analogue, CPT-11. However, exposure of KB cells to 42°C after treatment with VP-16 did not enhance the cytotoxicity induced by the drug. The formation of cleavable DNA-topoisomerase II-VP-16 complexes was also greatly increased by prior exposure to 42°C. Our present study proposes the hypothesis that the topoisomerase II gene might be one of the heat-shock-inducible genes and that hyperthermic anticancer therapy with topoisomerase II-targeting antitumor agents can be improved.

1 This work was partly supported by grant-in-aid for cancer research funds from the Ministry of Education, Science, and Culture of Japan and also from the Ministry of Human Health and Welfare, Japan.

2 To whom requests for reprints should be addressed, at Department of Biochemistry, Oita Medical University, Hasama-machi, Oita 879-55, Japan.

Received 8/10/92. Accepted 12/22/92.




This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
E Tiligada
Chemotherapy: induction of stress responses
Endocr. Relat. Cancer, December 1, 2006; 13(Supplement_1): S115 - S124.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. A. Joshi, Z. Wu, R. F. Reed, and D. P. Suttle
Nuclear Factor-Y Binding to the Topoisomerase IIalpha Promoter Is Inhibited by Both the p53 Tumor Suppressor and Anticancer Drugs
Mol. Pharmacol., February 1, 2003; 63(2): 359 - 367.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
E. U. Kurz, S. E. Wilson, K. B. Leader, B. P. Sampey, W. P. Allan, J. C. Yalowich, and D. J. Kroll
The Histone Deacetylase Inhibitor Sodium Butyrate Induces DNA Topoisomerase II{alpha} Expression and Confers Hypersensitivity to Etoposide in Human Leukemic Cell Lines
Mol. Cancer Ther., December 1, 2001; 1(2): 121 - 131.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Furukawa, T. Uchiumi, M. Nomoto, H. Takano, R. I. Morimoto, S. Naito, M. Kuwano, and K. Kohno
The Role of an Inverted CCAAT Element in Transcriptional Activation of the Human DNA Topoisomerase IIalpha Gene by Heat Shock
J. Biol. Chem., April 24, 1998; 273(17): 10550 - 10555.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Yokomizo, K. Kohno, M. Wada, M. Ono, C. S. Morrow, K. H. Cowan, and M. Kuwano
Markedly Decreased Expression of Glutathione S-Transferase [IMAGE] Gene in Human Cancer Cell Lines Resistant to Buthionine Sulfoximine, an Inhibitor of Cellular Glutathione Synthesis
J. Biol. Chem., August 18, 1995; 270(33): 19451 - 19457.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1993 by the American Association for Cancer Research.